AIDS In The USA: People, Papers, And Funding

“Better late than never,” one might say about the U.S. federal government’s response to AIDS, first identified in 1981. Only in the past few years has the government moved aggressively to fund the battle against the epidemic. Today, al- though federal funding has greatly increased, many continue to believe that it is still below what it should be. In the spring of 1987, AIDS researcher and immunochemist Paul Naylor of George Washington University called for a tripling of the

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the spring of 1987, AIDS researcher and immunochemist Paul Naylor of George Washington University called for a tripling of the then-current research budget for AIDS, which stood at close to half a billion dollars. That goal may now be in sight. Federal outlays for fiscal year 1988 will likely approach between $1 billion and $1.5 billion, which is the appropriated sum. And the president’s request for fiscal year 1989 is for $2.2 billion. Naylor now says, “We are beginning to approach levels of spending that could be considered maximally effective, given the available talent pool of researchers and technicians.” But he quickly adds, “It is important, however, that the government continue its commitment for more than the short term.”

The accompanying chart brings together three sets of data: (a) the number of diagnosed cases of AIDS per year since 1982; (b) the number of AIDS articles with at least ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • David Pendlebury

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Conceptual 3D image of DNA on a blue background.

Understanding the Nuts and Bolts of qPCR Assay Controls 

Bio-Rad
Takara Bio

Takara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutions

Sapio Sciences

Sapio Sciences Announces Enhanced Capabilities for Chemistry, Immunogenicity, GMP and Molecular Biology

Biotium Logo

Biotium Unveils the Most Sensitive Stains for DNA or RNA with New EMBER™ Ultra Agarose Gel Kits